Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kessel KA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 34
Tytuł:
Datenbankbasierte digitale retrospektive Auswertung von Patientenkollektiven in der Radioonkologie: Etablierung eines Workflows am Beispiel des Pankreaskarzinoms. (German)
Autorzy:
Kessel KA
Habermehl D
Bohn C
Jäger A
Floca RO
Zhang L
Bougatf N
Bendl R
Debus J
Combs SE
Kessel, K A
Habermehl, D
Bohn, C
Jäger, A
Floca, R O
Zhang, L
Bougatf, N
Bendl, R
Debus, J
Combs, S E
Pokaż więcej
Alternatywny tytuł:
[Database supported electronic retrospective analyses in radiation oncology: establishing a workflow using the example of pancreatic cancer]. (English)
Źródło:
Strahlentherapie und Onkologie; Dec2012, Vol. 188 Issue 12, p1119-1124, 6p
Czasopismo naukowe
Szczegóły
Tytuł:
Patient individual phase gating for stereotactic radiation therapy of early stage non-small cell lung cancer (NSCLC).
Autorzy:
Kraus KM; School of Medicine and Klinikum Rechts Der Isar, Department of Radiation Oncology, Technichal University of Munich (TUM), Munich, Germany. .
Oechsner M; School of Medicine and Klinikum Rechts Der Isar, Department of Radiation Oncology, Technichal University of Munich (TUM), Munich, Germany.
Wilkens JJ; School of Medicine and Klinikum Rechts Der Isar, Department of Radiation Oncology, Technichal University of Munich (TUM), Munich, Germany.
Kessel KA; School of Medicine and Klinikum Rechts Der Isar, Department of Radiation Oncology, Technichal University of Munich (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München (HMGU), Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Münch S; School of Medicine and Klinikum Rechts Der Isar, Department of Radiation Oncology, Technichal University of Munich (TUM), Munich, Germany.
Combs SE; School of Medicine and Klinikum Rechts Der Isar, Department of Radiation Oncology, Technichal University of Munich (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München (HMGU), Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 12; Vol. 11 (1), pp. 5870. Date of Electronic Publication: 2021 Mar 12.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Radiosurgery*
Carcinoma, Non-Small-Cell Lung/*radiotherapy
Lung Neoplasms/*radiotherapy
Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/diagnostic imaging ; Dose-Response Relationship, Radiation ; Four-Dimensional Computed Tomography ; Humans ; Lung Neoplasms/diagnostic imaging ; Middle Aged ; Motion ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted ; Respiration ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Is local radiotherapy a viable option for patients with an opening of the ventricles during surgical resection of brain metastases?
Autorzy:
Scharl S; Department of Radiation Oncology, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.
Kessel KA; Department of Radiation Oncology, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Diehl C; Department of Radiation Oncology, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.
Gempt J; Department of Neurosurgery, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.
Meyer B; Department of Neurosurgery, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.
Zimmer C; Department of Diagnostic and Interventional Neuroradiology, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.
Straube C; Department of Radiation Oncology, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany.; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Combs SE; Department of Radiation Oncology, Technische Universität München (TUM), Ismaninger Straße 22, Munich, Germany. .; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany. .; Deutsches Konsortium Für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2020 Dec 10; Vol. 15 (1), pp. 276. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji:
Journal Article
MeSH Terms:
Brain Neoplasms/*radiotherapy
Cerebral Ventricles/*surgery
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/mortality ; Brain Neoplasms/surgery ; Humans ; Meningeal Neoplasms/epidemiology ; Middle Aged ; Neoplasm Recurrence, Local ; Radiosurgery ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
MRI- and CT-determined changes of dysphagia / aspiration-related structures (DARS) during and after radiotherapy.
Autorzy:
Pigorsch SU; Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.
May C; Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.
Kessel KA; Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany.
Graf S; Department of Otorhinolaryngology, Technical University of Munich (TUM), Munich, Germany.
Bier H; Department of Otorhinolaryngology, Technical University of Munich (TUM), Munich, Germany.
Nüsslin F; Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.
Waschulzik B; Institute of Medical Informatics, Statistics and Epidemiology, Technical University of Munich (TUM), Munich, Germany.
Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Sep 02; Vol. 15 (9), pp. e0237501. Date of Electronic Publication: 2020 Sep 02 (Print Publication: 2020).
Typ publikacji:
Journal Article
MeSH Terms:
Magnetic Resonance Imaging*
Suction*
Tomography, X-Ray Computed*
Deglutition Disorders/*diagnostic imaging
Deglutition Disorders/*radiotherapy
Adult ; Aged ; Deglutition ; Deglutition Disorders/physiopathology ; Female ; Humans ; Logistic Models ; Male ; Middle Aged ; Retrospective Studies ; Surveys and Questionnaires ; Voice ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Autorzy:
Voglhuber T; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany. .
Kessel KA; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Heidelberg, Germany.
Oechsner M; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Vogel MME; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Gschwend JE; Department of Urology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.
Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Heidelberg, Germany.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 Jun 08; Vol. 20 (1), pp. 536. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji:
Journal Article
MeSH Terms:
Adrenal Gland Neoplasms/*radiotherapy
Radiation Injuries/*epidemiology
Radiosurgery/*methods
Adrenal Gland Neoplasms/mortality ; Adrenal Gland Neoplasms/secondary ; Adrenal Glands/diagnostic imaging ; Adrenal Glands/pathology ; Adrenal Glands/radiation effects ; Adult ; Aged ; Aged, 80 and over ; Asymptomatic Diseases/mortality ; Asymptomatic Diseases/therapy ; Contrast Media/administration & dosage ; Disease Progression ; Dose Fractionation, Radiation ; Dose-Response Relationship, Radiation ; Female ; Humans ; Male ; Middle Aged ; Progression-Free Survival ; Radiation Injuries/diagnosis ; Radiation Injuries/etiology ; Radiation Injuries/prevention & control ; Radiosurgery/adverse effects ; Radiotherapy Planning, Computer-Assisted ; Retrospective Studies ; Severity of Illness Index ; Tomography, X-Ray Computed
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome.
Autorzy:
Kessel KA; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany. kerstin.kessel@tum.de.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany. kerstin.kessel@tum.de.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site Munich, Munich, Germany. kerstin.kessel@tum.de.
Weber W; Department of Nuclear Medicine, Technical University of Munich (TUM), Ismaninger Straße, 22, Munich, Germany.
Yakushev I; Department of Nuclear Medicine, Technical University of Munich (TUM), Ismaninger Straße, 22, Munich, Germany.
Fischer H; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.
Voglhuber T; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.
Diehl C; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site Munich, Munich, Germany.
Straube C; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site Munich, Munich, Germany.
Zimmer C; Department of Neuroradiology, Technical University of Munich (TUM), Ismaninger Straße, 22, Munich, Germany.
Wiestler B; Department of Neuroradiology, Technical University of Munich (TUM), Ismaninger Straße, 22, Munich, Germany.
Gempt J; Department of Neurosurgery, Technical University of Munich (TUM), Ismaninger Straße, 22, Munich, Germany.
Meyer B; Department of Neurosurgery, Technical University of Munich (TUM), Ismaninger Straße, 22, Munich, Germany.
Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Jun; Vol. 47 (6), pp. 1391-1399. Date of Electronic Publication: 2019 Nov 22.
Typ publikacji:
Journal Article
MeSH Terms:
Meningeal Neoplasms*/diagnostic imaging
Meningeal Neoplasms*/radiotherapy
Meningioma*/diagnostic imaging
Meningioma*/radiotherapy
Radiosurgery*
Humans ; Neoplasm Recurrence, Local ; Positron-Emission Tomography ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO).
Autorzy:
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany. kerstin.kessel@tum.de.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany. kerstin.kessel@tum.de.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany. kerstin.kessel@tum.de.
Grosser RCE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.
Kraus KM; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.
Hoffmann H; Division of Thoracic Surgery, Technical University of Munich (TUM), Munich, Germany.
Oechsner M; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2020 May 19; Vol. 20 (1), pp. 442. Date of Electronic Publication: 2020 May 19.
Typ publikacji:
Journal Article
MeSH Terms:
Patient Reported Outcome Measures*
Lung Neoplasms/*mortality
Neoplasms/*mortality
Radiosurgery/*mortality
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Child ; Female ; Follow-Up Studies ; Humans ; Lung Neoplasms/secondary ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Neoplasms/pathology ; Neoplasms/surgery ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma.
Autorzy:
Straube C; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany. .; Deutsches Konsortium für translationale Krebsforschung (dktk), Partner Site Munich, Munich, Germany. .
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.
Antoni S; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; Department of Neuropathology, Technical University of Munich, Munich, Germany.
Gempt J; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Meyer B; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Schlegel J; Department of Neuropathology, Technical University of Munich, Munich, Germany.
Schmidt-Graf F; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, School of Medicine, Munich, Germany.; Deutsches Konsortium für translationale Krebsforschung (dktk), Partner Site Munich, Munich, Germany.; Department of Radiation Sciences (DRS), Institut für Strahlenmedizin (IRM), Helmholtz Zentrum München (HMGU), Neuherberg, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2020 May 06; Vol. 15 (1), pp. 97. Date of Electronic Publication: 2020 May 06.
Typ publikacji:
Journal Article
MeSH Terms:
Glioblastoma/*diagnosis
Glioblastoma/*mortality
Aged ; Aged, 80 and over ; Combined Modality Therapy ; Female ; Glioblastoma/pathology ; Glioblastoma/therapy ; Humans ; Kaplan-Meier Estimate ; Male ; Prognosis ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Stereotactic irradiation of the resection cavity after surgical resection of brain metastases - when is the right timing?
Autorzy:
Scharl S; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.
Kirstein A; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Oberschleißheim, Germany.
Kessel KA; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Oberschleißheim, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site, Munich, Germany.
Diehl C; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.
Oechsner M; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.
Straube C; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site, Munich, Germany.
Meyer B; Department of Neurosurgery, Technische Universität München (TUM), Munich, Germany.
Zimmer C; Department of Diagnostic and Interventional Neuroradiology, Technische Universität München (TUM), Munich, Germany.
Combs SE; Department of Radiation Oncology, Technische Universität München (TUM), Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, Oberschleißheim, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site, Munich, Germany.
Pokaż więcej
Źródło:
Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2019 Dec; Vol. 58 (12), pp. 1714-1719. Date of Electronic Publication: 2019 Aug 01.
Typ publikacji:
Journal Article
MeSH Terms:
Radiosurgery*/mortality
Time-to-Treatment*
Brain Neoplasms/*radiotherapy
Brain Neoplasms/*surgery
Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Brain Neoplasms/mortality ; Brain Neoplasms/secondary ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Recurrence, Local ; Radiotherapy, Adjuvant ; Time Factors ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Patient-Reported Outcome (PRO) as an Addition to Long-Term Results after High-Precision Stereotactic Radiotherapy in Patients with Secreting and Non-Secreting Pituitary Adenomas: A Retrospective Cohort Study up to 17-Years Follow-Up.
Autorzy:
Kessel KA; Department of Radiation Oncology, Technical University of Munich (TUM), 81675 Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site, 81675 Munich, Germany.
Diehl CD; Department of Radiation Oncology, Technical University of Munich (TUM), 81675 Munich, Germany.
Oechsner M; Department of Radiation Oncology, Technical University of Munich (TUM), 81675 Munich, Germany.
Meyer B; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site, 81675 Munich, Germany.; Department of Neurosurgery, Technical University of Munich (TUM), 81675 Munich, Germany.
Gempt J; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site, 81675 Munich, Germany.; Department of Neurosurgery, Technical University of Munich (TUM), 81675 Munich, Germany.
Zimmer C; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site, 81675 Munich, Germany.; Department of Neuroradiology, Technical University of Munich (TUM), 81675 Munich, Germany.
Schmidt-Graf F; Department of Neurology, Technical University of Munich (TUM), 81675 Munich, Germany.
Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), 81675 Munich, Germany.; Institute of Radiation Medicine (IRM), Helmholtz Zentrum München, 85764 Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), DKTK Partner Site, 81675 Munich, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2019 Nov 27; Vol. 11 (12). Date of Electronic Publication: 2019 Nov 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Adjuvant versus early salvage radiotherapy: outcome of patients with prostate cancer treated with postoperative radiotherapy after radical prostatectomy.
Autorzy:
Vogel MME; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institute for Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institute for Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Schiller K; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Devecka M; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Gschwend JE; Department of Urology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Weichert W; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Institute of Pathology, Technical University of Munich (TUM), Munich, Germany.
Wilkens JJ; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany. .; Institute for Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany. .; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany. .
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2019 Nov 11; Vol. 14 (1), pp. 198. Date of Electronic Publication: 2019 Nov 11.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Prostatectomy*
Prostatic Neoplasms/*radiotherapy
Prostatic Neoplasms/*surgery
Radiotherapy/*methods
Salvage Therapy/*methods
Adult ; Aged ; Aged, 80 and over ; Disease-Free Survival ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Postoperative Period ; Propensity Score ; Proportional Hazards Models ; Prostate-Specific Antigen/analysis ; Radiotherapy, Adjuvant ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cytosolic Hsp70 as a biomarker to predict clinical outcome in patients with glioblastoma.
Autorzy:
Lämmer F; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Pathology, Technical University of Munich, Munich, Germany.
Delbridge C; Institute of Pathology, Technical University of Munich, Munich, Germany.
Würstle S; Institute of Pathology, Technical University of Munich, Munich, Germany.
Neff F; Institute of Pathology, Klinikum Bogenhausen, Städtisches Klinikum München GmbH, Munich, Germany.
Meyer B; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
Schlegel J; Institute of Pathology, Technical University of Munich, Munich, Germany.
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.
Schmid TE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.
Schilling D; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.; Institute of Radiation Medicine (IRM), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (dktk), Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Aug 20; Vol. 14 (8), pp. e0221502. Date of Electronic Publication: 2019 Aug 20 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor/*metabolism
Brain Neoplasms/*metabolism
Cytosol/*metabolism
Glioblastoma/*metabolism
HSP70 Heat-Shock Proteins/*metabolism
Adult ; Aged ; Brain Neoplasms/pathology ; Disease-Free Survival ; Female ; Glioblastoma/pathology ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Interfraction variation and dosimetric changes during image-guided radiation therapy in prostate cancer patients.
Autorzy:
Fuchs F; Department of Radiation Oncology, Technical University of Munich (TUM), Germany.
Habl G; Department of Radiation Oncology, Technical University of Munich (TUM), Germany.
Devečka M; Department of Radiation Oncology, Technical University of Munich (TUM), Germany.
Kampfer S; Department of Radiation Oncology, Technical University of Munich (TUM), Germany.
Combs SE; Department of Radiation Oncology, Technical University of Munich (TUM), Germany.; Institute of Radiation Medicine, Department of Radiation Sciences, Helmholtz Zentrum München, Neuherberg, Germany.
Kessel KA; Department of Radiation Oncology, Technical University of Munich (TUM), Germany.; Institute of Radiation Medicine, Department of Radiation Sciences, Helmholtz Zentrum München, Neuherberg, Germany.
Pokaż więcej
Źródło:
Radiation oncology journal [Radiat Oncol J] 2019 Jun; Vol. 37 (2), pp. 127-133. Date of Electronic Publication: 2019 Mar 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
Autorzy:
Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany. .; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany. .
Knie C; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Habermehl D; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Kampfer S; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Dapper H; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Devecka M; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
von Eisenhart-Rothe R; Department of Orthopaedic Surgery, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Specht K; Department of Pathology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Weichert W; Department of Pathology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Wörtler K; Department of Radiology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Knebel C; Department of Orthopaedic Surgery, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.
Wilkens JJ; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Straße 22, 81675, Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, Neuherberg, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2019 Jan 09; Vol. 14 (1), pp. 2. Date of Electronic Publication: 2019 Jan 09.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Extremities/*radiation effects
Neoadjuvant Therapy/*methods
Neoplasm Recurrence, Local/*radiotherapy
Radiotherapy, Image-Guided/*methods
Radiotherapy, Intensity-Modulated/*methods
Sarcoma/*radiotherapy
Adult ; Aged ; Aged, 80 and over ; Extremities/pathology ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Radiotherapy Dosage ; Radiotherapy Planning, Computer-Assisted/methods ; Radiotherapy, Adjuvant ; Sarcoma/pathology ; Survival Rate ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme.
Autorzy:
Peeken JC; Department of Radiation Oncology, Klinikum rechts der Isar der Technischem Universität München (TUM), München, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Neuherberg, Germany.
Goldberg T; Allianz SE, Munich, Germany.
Pyka T; Department of Nuclear Medicine, Klinikum rechts der Isar der Technischen Universität München (TUM), Munich, Germany.
Bernhofer M; Department for Bioinformatics and Computational Biology, Technical University of Munich (TUM), Garching, Germany.
Wiestler B; Department of Neuroradiology, Klinikum rechts der Isar der Technischen Universität, Munich (TUM), München, Germany.
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar der Technischem Universität München (TUM), München, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Neuherberg, Germany.
Tafti PD; Allianz SE, Munich, Germany.
Nüsslin F; Department of Radiation Oncology, Klinikum rechts der Isar der Technischem Universität München (TUM), München, Germany.
Braun AE; Allianz SE, Munich, Germany.
Zimmer C; Department of Neuroradiology, Klinikum rechts der Isar der Technischen Universität, Munich (TUM), München, Germany.
Rost B; Department of Nuclear Medicine, Klinikum rechts der Isar der Technischen Universität München (TUM), Munich, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar der Technischem Universität München (TUM), München, Germany.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.; Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Neuherberg, Germany.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Jan; Vol. 8 (1), pp. 128-136. Date of Electronic Publication: 2018 Dec 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Machine Learning*
Models, Theoretical*
Brain Neoplasms/*classification
Glioblastoma/*classification
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/pathology ; Brain Neoplasms/radiotherapy ; Chemotherapy, Adjuvant ; Female ; Glioblastoma/diagnostic imaging ; Glioblastoma/pathology ; Glioblastoma/radiotherapy ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multimodal Imaging ; Positron Emission Tomography Computed Tomography ; Prognosis ; Survival Analysis ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine.
Autorzy:
Wank M; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, 85764 Neuherberg, Germany. .; Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, 81675 Munich, Germany. .
Schilling D; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, 85764 Neuherberg, Germany. .; Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .
Schmid TE; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, 85764 Neuherberg, Germany. .; Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .
Meyer B; Department of Neurosurgery, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .
Gempt J; Department of Neurosurgery, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .
Barz M; Department of Neurosurgery, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .
Schlegel J; Department of Neuropathology, Technical University of Munich (TUM), 81675 Munich, Germany. .
Liesche F; Department of Neuropathology, Technical University of Munich (TUM), 81675 Munich, Germany. .
Kessel KA; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, 85764 Neuherberg, Germany. Kerstin.kessel@tum.de.; Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. Kerstin.kessel@tum.de.; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, 81675 Munich, Germany. Kerstin.kessel@tum.de.
Wiestler B; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany. .
Bette S; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany. .
Zimmer C; Department of Neuroradiology, Klinikum rechts der Isar, Technische Universität München, 81675 Munich, Germany. .
Combs SE; Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, 85764 Neuherberg, Germany. .; Department of Radiation Oncology, Technical University of Munich (TUM), Klinikum rechts der Isar, 81675 Munich, Germany. .; Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, 81675 Munich, Germany. .
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2018 Nov 20; Vol. 10 (11). Date of Electronic Publication: 2018 Nov 20.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A trend towards a more intense adjuvant treatment of low-grade-gliomas in tertiary centers in Germany after RTOG 9802 - results from a multi-center survey.
Autorzy:
Straube C; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany. .; Deutsches Konsortium Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany. .
Kessel KA; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institut für Innovative Radiotherapie (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Munich, Germany.; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Schmidt-Graf F; Department of Neurology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Krieg SM; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Meyer B; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Gempt J; Department of Neurosurgery, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.
Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Institut für Innovative Radiotherapie (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Munich, Germany.; Deutsches Konsortium Translationale Krebsforschung (DKTK), Partner Site Munich, Munich, Germany.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2018 Sep 21; Vol. 18 (1), pp. 907. Date of Electronic Publication: 2018 Sep 21.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Glioma/*epidemiology
Adult ; Combined Modality Therapy ; Female ; Germany/epidemiology ; Glioma/diagnostic imaging ; Glioma/pathology ; Glioma/therapy ; Health Care Surveys ; Humans ; Male ; Middle Aged ; Multimodal Imaging/methods ; Neoplasm Grading ; Neoplasm Staging ; Practice Guidelines as Topic ; Surveys and Questionnaires ; Tertiary Care Centers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Evaluation of particle radiotherapy for the re-irradiation of recurrent intracranial meningioma.
Autorzy:
El Shafie RA; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. .; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany. .
Czech M; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Kessel KA; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany.; Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Germany.
Habermehl D; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany.; Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Germany.
Weber D; Institute for Medical Biometry and Informatics (IMBI), Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Rieken S; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.
Bougatf N; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.
Jäkel O; Department of Medical Physics, Deutsches Krebsforschungszentrum, Im Neuenheimer Feld 270, 69120, Heidelberg, Germany.
Debus J; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Heavy Ion Therapy Center (HIT), Heidelberg University Hospital, Im Neuenheimer Feld 450, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Radiation Oncology (E050), German Cancer Research Center (dkfz), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Combs SE; Department of Radiation Oncology, University Hospital of Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.; Department of Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675, Munich, Germany.; Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Oberschleißheim, Germany.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2018 May 08; Vol. 13 (1), pp. 86. Date of Electronic Publication: 2018 May 08.
Typ publikacji:
Evaluation Study; Journal Article
MeSH Terms:
Re-Irradiation*
Salvage Therapy*
Heavy Ion Radiotherapy/*methods
Meningeal Neoplasms/*radiotherapy
Meningioma/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Radiotherapy Planning, Computer-Assisted/*methods
Adolescent ; Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Meningeal Neoplasms/mortality ; Meningeal Neoplasms/pathology ; Meningioma/mortality ; Meningioma/pathology ; Middle Aged ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Prognosis ; Radiotherapy Dosage ; Radiotherapy, Intensity-Modulated/methods ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
Autorzy:
Combs SE; Department of Radiation Oncology, Technical University Munich (TUM), Munich, Germany.; Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Neuherberg, Germany.; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.
Niyazi M; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Adeberg S; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg University, Heidelberg, Germany.
Bougatf N; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg University, Heidelberg, Germany.
Kaul D; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, Charité-University Hospital Berlin, Berlin, Germany.
Fleischmann DF; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Gruen A; Department of Radiation Oncology, Charité-University Hospital Berlin, Berlin, Germany.
Fokas E; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Hospital Johann Wolfgang Goethe University, Frankfurt, Germany.
Rödel CM; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Hospital Johann Wolfgang Goethe University, Frankfurt, Germany.
Eckert F; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, Faculty of Medicine, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany.
Paulsen F; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.
Oehlke O; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany.
Grosu AL; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Medical Center Freiburg, Freiburg, Germany.
Seidlitz A; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology and OncoRay, National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Lattermann A; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology and OncoRay, National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Krause M; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology and OncoRay, National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.
Baumann M; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology and OncoRay, National Center for Radiation Research in Oncology (NCRO), Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Institute of Radiooncology, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; Partner site Dresden, National Center for Tumor Diseases (NCT), Dresden, Germany.; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
Guberina M; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Stuschke M; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Budach V; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, Charité-University Hospital Berlin, Berlin, Germany.
Belka C; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Debus J; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.; Department of Radiation Oncology, Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg University, Heidelberg, Germany.
Kessel KA; Department of Radiation Oncology, Technical University Munich (TUM), Munich, Germany.; Institute of Innovative Radiotherapy (iRT), Helmholtz Zentrum München, Neuherberg, Germany.; Partner sites Munich, Heidelberg, Berlin, Frankfurt, Tübingen, Freiburg, Dresden, Essen, German Cancer Consortium (DKTK), Berlin, Germany.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2018 May; Vol. 7 (5), pp. 1742-1749. Date of Electronic Publication: 2018 Mar 23.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Brain Neoplasms/*radiotherapy
Glioma/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Re-Irradiation/*methods
Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Germany ; Humans ; Male ; Middle Aged ; Prognosis ; Radiation Dosage ; Radiotherapy, Intensity-Modulated/methods ; Retrospective Studies ; Survival Analysis ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 34

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies